India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
Bio-Pharma SHAKTI Scheme: Strengthening India’s Biopharmaceutical Sector
Bio-Pharma SHAKTI Scheme: Strengthening India’s Biopharmaceutical Sector
The Government of India has proposed a ₹10,000-crore Bio-Pharma SHAKTI Scheme to strengthen the country’s biopharmaceutical ecosystem and enhance self-reliance in advanced healthcare technologies. The scheme focuses on supporting research and development (R&D), advanced manufacturing, and infrastructure creation in areas such as vaccines, biosimilars, biologics, and cell and gene therapies. It aims to reduce import dependence on high-value biopharma products and improve domestic supply-chain resilience.
The initiative is expected to promote industry–academia collaboration, technology transfer, private investment, and high-skilled employment. Overall, the scheme aligns with national priorities such as Atmanirbhar Bharat, Make in India, and healthcare security.
Related Question:
Q. With reference to the proposed Bio-Pharma SHAKTI Scheme, consider the following statements:
It aims to strengthen India’s biopharmaceutical sector through support to research, manufacturing, and infrastructure.
The scheme focuses on areas such as vaccines, biosimilars, biologics, and cell and gene therapies.
One of its objectives is to reduce India’s dependence on imports of high-value biopharma products.
The scheme is primarily targeted at the agricultural biotechnology sector.
Which of the statements given above are correct?
(a) 1 and 2 only
(b) 1, 2 and 3 only
(c) 2 and 4 only
(d) 1, 2, 3 and 4
